As part of my Prime Life journey, I've shared how knowing ourselves — truly understanding our health status — is the foundation for everything else. Today, I want to take that one step further. Let me walk you through a real-life case study: my own blood test data over the past seven years.
Specifically, I'll focus on two categories of biomarkers that carry outsized weight when it comes to long-term health: blood lipids and blood glucose.
These metrics tend to change slowly and silently. They rarely trigger discomfort, rarely cause alarm bells to ring. But in that silence hides the thunder — because these very markers are the prelude to two of the loudest and deadliest diseases we know: cardiovascular disease and type 2 diabetes.
The (Unexpected) Complexity of Cleaning Up Your Own Data
My reports span from 2017 to late 2024, just before I committed to taking stronger action. Pulling all that data together wasn't simple. The files were scattered — some PDFs, some screenshots, some physical paper. The terminology was inconsistent: messy abbreviations, units jumping around — cholesterol in mg/dL one year, mmol/L the next. Even the "normal reference ranges" varied across labs and years.
Worse, not every test captured the metrics I wanted to track.
And if I, someone already deeply immersed in this field, found it tedious — imagine how off-putting it must feel for the average person. But I'll say this: it doesn't take rocket science to get through it. A bit of patience and curiosity goes a long way.
Eventually, I cleaned and organized the key blood lipid and glucose markers. Here's what the data revealed after I organized it into a table — then broke it down further into charts for clarity.
Lipids: Some Wins, Some Red Flags
Observation #1: HDL-C has been consistently healthy; TG significantly improved.
My HDL-C (high-density lipoprotein cholesterol — "the good cholesterol") has never dropped below the healthy threshold (>1.0 mmol/L). Meanwhile, my triglycerides (TG) showed clear improvement after 2023. That's roughly when I started tightening up my nutrition. The improvement in TG might be one of the first tangible signs that those efforts are paying off.
Observation #2: LDL-C has stayed stubbornly high.
Here's where things get less encouraging. My LDL-C (low-density lipoprotein cholesterol — "bad cholesterol") has been above the recommended limit (3.35 mmol/L) since 2017 — eight years ago. From 2017 to 2024, it's hovered stubbornly between 3.4 and 3.8. Even after my dietary improvements, it didn't budge meaningfully.
So while my total cholesterol has consistently been on the high end, the main culprit has been LDL-C — not TG.
This tells me something critical: my body responds to lifestyle changes in TG relatively quickly, but LDL-C is far more resistant. Which means that managing LDL-C may require more aggressive strategies — including, potentially, pharmacological support.
Glucose: A Quiet, Steady Climb
Observation #3: HbA1c is on the rise — and creeping into prediabetes territory.
Fasting blood glucose (FBG) is still within the normal range. In fact, it even dropped slightly in 2023–2024. But FBG is a fickle number — easily influenced by last night's dinner, this morning's stress, or how well I slept. In later articles, I'll share my experience with Continuous Glucose Monitoring (CGM), which shows two-week continuous trends in blood sugar fluctuations and is a lot more telling.
HbA1c, on the other hand, reflects your average blood sugar over the past 2–3 months. It's a more reliable metric for our stable glucose level. And that number has been ticking up, year after year. As of late 2024, I've officially entered the lower bound of the "prediabetes" range.
That's not a diagnosis. But it is a signal — a warning that my insulin sensitivity is declining and my metabolic system is under mounting pressure.
The rise has been subtle. Easy to miss. But it's real — and it deserves attention now, not later.
Why Trends Matter More Than Snapshots
Here's my biggest takeaway from this exercise:
Don't let a single "normal" test result fool you into thinking everything's fine.
Take LDL-C. It's been mildly elevated for eight years. No single report screamed for intervention. But when you zoom out, the picture becomes clear: my blood vessels have been under low-grade assault for nearly a decade. Chronic pressure, slowly building. It's the kind of trend that leads to plaque, arterial stiffening, and eventually — disaster. Left unaddressed, this kind of persistent elevation makes it nearly impossible to achieve the three core goals of Prime Life.
Same for HbA1c. The upward creep is slow, but steady. Without this trend analysis, I might have missed it entirely. But the good news is — I'm catching it at the edge. There's still time to change course.
Which brings me to this: if you're young, healthy, and your reports always say "normal," you should still track your numbers over time. You might be able to see a risk five — maybe even ten — years before it would've otherwise been noticed.
That's the real power of trend analysis.
Looking Ahead
I'll keep updating these trends regularly — not just for lipids and glucose, but for other systems too. This is part of my ongoing effort to build a real-time, personalized health dashboard.
And I'm optimistic. With focused interventions and consistent tracking over the next 6 to 12 months, I believe I'll start seeing meaningful shifts in these numbers.
This is the kind of long game Prime Life demands — not panicked reaction, but proactive precision.
And it starts with listening to what your quiet numbers have been whispering all along.
